Custirsen

DRUG3 trials

Sponsors

Achieve Life Sciences

Conditions

Cardiac Conduction and RepolarizationNon-Small Cell Lung CancerProstate Cancer

Phase 1

Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization

CompletedNCT01874561

Achieve Life SciencesCardiac Conduction and Repolarization

Start: 2013-05-31End: 2014-01-31Updated: 2016-10-10

Phase 3

Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer

CompletedNCT01188187

Achieve Life SciencesProstate Cancer

Start: 2010-11-30End: 2014-06-30Updated: 2016-10-14

A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

CompletedNCT01630733

Achieve Life SciencesNon-Small Cell Lung Cancer

Start: 2012-10-24End: 2016-11-17Updated: 2026-04-15

Related Papers

Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial.

2017-03-0869 citations

Phase III SYNERGY trial: Docetaxel +/- custirsen and overall survival in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and poor prognosis.

Journal of Clinical Oncology2015-05-2021 citations